Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Solazyme Inc (NASDAQ:SZYM)

2.33
Delayed Data
As of 4:00pm ET
 -0.03 / -1.27%
Today’s Change
1.18
Today|||52-Week Range
4.00
-6.05%
Year-to-Date
No recent news for Solazyme Inc.

Today’s Trading

Previous close2.36
Today’s open2.36
Day’s range2.27 - 2.39
Volume410,620
Average volume (3 months)761,142
Market cap$197.1M
Dividend yield--
Data as of 4:00pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+17.76%
Earnings growth (this year)+20.17%
Earnings growth (next 5 years)+683.60%
Revenue growth (last year)-23.61%
P/E ratioNM
Price/Sales4.31
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...-0.42-7.30%
ENZYEnzymotec Ltd0.000.00%
AKTXAkari Therapeutics P...-1.10-6.42%
PFNXPfenex Inc+0.45+5.60%
Data as of 4:01pm ET, 05/03/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$46.1M
Annual profit (last year)-$141.4M
Net profit margin-306.62%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
Chairman &
Chief Executive Officer
Jonathan S. Wolfson
Chief Operating &
Financial Officer
Tyler W. Painter
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs